Aya Jakobovits - 16 Feb 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Director
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
16 Feb 2022
Net transactions value
-$59,328
Form type
4
Filing time
17 Feb 2022, 17:10:06 UTC
Previous filing
14 Feb 2022
Next filing
11 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $29,664 -2,000 -0.56% $14.83* 358,343 16 Feb 2022 See Footnote F1, F2, F3
transaction ACET Common Stock Sale $29,664 -2,000 -0.56% $14.83* 358,345 16 Feb 2022 See Footnote F1, F2, F4
holding ACET Common Stock 138,076 16 Feb 2022 See Footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.52 to $15.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
F4 Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
F5 Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.